Bone Marrow TransplantationTransplantation, HomologousGraft vs Host DiseaseBone MarrowBone Marrow CellsWhole-Body IrradiationLeukemiaAnemia, AplasticTransplantation ConditioningTransplantation, AutologousTransplantation ChimeraTissue DonorsBusulfanLeukemia, Myelogenous, Chronic, BCR-ABL PositiveGraft SurvivalHematopoietic Stem Cell TransplantationHistocompatibility TestingLeukocyte TransfusionRecurrenceGraft vs Tumor EffectHistocompatibilityRadiation ChimeraLeukemia, Myeloid, AcutePrecursor Cell Lymphoblastic Leukemia-LymphomaCyclophosphamideGraft vs Host ReactionHematologic NeoplasmsLymphocyte DepletionRemission InductionGraft vs Leukemia EffectImmunosuppressive AgentsTransplantation, IsogeneicAcute DiseaseBone Marrow PurgingHematopoietic Stem CellsBone and BonesLymphocyte TransfusionHepatic Veno-Occlusive DiseaseLeukemia, MyeloidMice, Inbred C57BLGraft RejectionImmunosuppressionCombined Modality TherapyTime FactorsChimeraT-LymphocytesTreatment OutcomeHematopoiesisMyelodysplastic SyndromesCyclosporineKidney TransplantationTransplantation ImmunologyNuclear FamilyLiver TransplantationSurvival AnalysisCytomegalovirus InfectionsActuarial AnalysisBone Marrow DiseasesRetrospective StudiesHLA AntigensHematologic DiseasesFatal OutcomeMice, Inbred BALB CLymphoma, Non-HodgkinBone Marrow ExaminationSevere Combined ImmunodeficiencySurvival RateCytarabineFollow-Up StudiesSpleenAntineoplastic Combined Chemotherapy ProtocolsPancytopeniaDisease-Free SurvivalBone Marrow NeoplasmsGranulocyte Colony-Stimulating FactorLeukocyte CountHeart TransplantationStem Cell TransplantationInfectionColony-Forming Units AssayLeukemia, Myelomonocytic, AcuteAnemia, Refractory, with Excess of BlastsLymphomaImmunocompromised HostFlow CytometryMethotrexateMultiple MyelomaAntilymphocyte SerumEtoposideGanciclovirNeoplasm, ResidualCyclosporinsPrognosisImmunophenotypingLung TransplantationMice, Inbred C3HThymus GlandBone RemodelingMice, Inbred AKRCell Differentiation